Evidence map›Paper›PMID 25304194›Full record

ReviewTrends in microbiology2014

Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding.

Liang Chen, Barun Mathema, Kalyan D Chavda, Frank R DeLeo, Robert A Bonomo, Barry N Kreiswirth

Open access · greenAbstract readReview
In one paragraph

Review in Trends in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 329 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
329citing papers in PubMed, 2 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

329 citing papers in PubMed, 2 syntheses or guidelines pooled it, 540 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. A posttranslational modification of fimbriae drives pathogenicity inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. TnMicrobial genomics · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026
    Review
  17. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Expanding Threat of Carbapenemase-ProducingbioRxiv : the preprint server for biology · 2026
    Article
  20. Article

269 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Liang ChenPublic Research Institute TB Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Barun MathemaPublic Research Institute TB Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
Kalyan D ChavdaPublic Research Institute TB Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Frank R DeLeoLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Robert A BonomoResearch Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH 44106, USA.
Barry N KreiswirthPublic Research Institute TB Center, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA. Electronic address: kreiswba@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USLouis Stokes Cleveland VA Medical Center · USNational Institute of Allergy and Infectious Diseases · US

Funding

Basis for Success of Multidrug-Resistant EnterobacteriaceaeZIAAI001195 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2014 to 2025
$11.9M
The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
Intramural NIH HHSNIAID NIH HHS 1R01AI090155NIAID NIH HHS R01 AI063517NIAID NIH HHS R01AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01AI072219NIAID NIH HHS R01 AI090155
6 · The paper itself

Abstract

Klebsiella pneumoniae carbapenemases (KPCs) were first identified in 1996 in the USA. Since then, regional outbreaks of KPC-producing K. pneumoniae (KPC-Kp) have occurred in the USA, and have spread internationally. Dissemination of blaKPC involves both horizontal transfer of blaKPC genes and plasmids, and clonal spread. Of epidemiological significance, the international spread of KPC-producing K. pneumoniae is primarily associated with a single multilocus sequence type (ST), ST258, and its related variants. However, the molecular factors contributing to the success of ST258 largely remain unclear. In this review, we discuss the recent progresses in understanding KPC-producing K. pneumoniae that are contributing to our knowledge of plasmid and genome composition and structure among the KPC epidemic clone, and we identify possible factors that influence its epidemiological success.

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenemsDNA Transposable ElementsDrug Resistance, BacterialGenomicsHumansKlebsiella InfectionsKlebsiella pneumoniaeMultilocus Sequence TypingPlasmidsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsDNA Transposable Elementscarbapenem-resistantKlebsiella pneumoniae carbapenemaseST258

Identifiers

PMID25304194
PMCPMC4365952
OpenAlexW2078043965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.